Related references
Note: Only part of the references are listed.Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System
Annalise Di Marco et al.
CELLS (2020)
Commentary on Fit-For-Purpose Models for Regulatory Applications
Yaning Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Tight junction proteins at the blood-brain barrier: far more than claudin-5
Philipp Berndt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Claudin-5: gatekeeper of neurological function
Chris Greene et al.
FLUIDS AND BARRIERS OF THE CNS (2019)
Modulation of Intestinal Epithelial Permeability in Differentiated Caco-2 Cells Exposed to Aflatoxin M1 and Ochratoxin A Individually or Collectively
Yanan Gao et al.
TOXINS (2018)
In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain
Hassan Pezeshgi Modarres et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Evaluating opportunities for advancing the use of alternative methods in risk assessment through the development of fit-for-purpose in vitro assays
Patrick D. McMullen et al.
TOXICOLOGY IN VITRO (2018)
In-vitro blood-brain barrier modeling: A review of modern and fast-advancing technologies
Farzane Sivandzade et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Mechanism of drug extrusion by brain endothelial cells via lysosomal drug trapping and disposal by neutrophils
Andreas Noack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
New experimental models of the blood-brain barrier for CNS drug discovery
Mohammad A. Kaisar et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
Limitations of the hCMEC/D3 Cell Line as a Model for Aβ Clearance by the Human Blood-brain Barrier
Elisanne A. L. M. Biemans et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP
Mariline Gameiro et al.
MOLECULES (2017)
Paving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells
Karin Lauschke et al.
STEM CELLS AND DEVELOPMENT (2017)
Cross-over endocytosis of claudins is mediated by interactions via their extracellular loops
Nora Gehne et al.
PLOS ONE (2017)
Claudin-5 regulates blood-brain barrier permeability by modifying brain microvascular endothelial cell proliferation, migration, and adhesion to prevent lung cancer metastasis
Shun-Chang Ma et al.
CNS NEUROSCIENCE & THERAPEUTICS (2017)
Immortalized endothelial cell lines for in vitro blood-brain barrier models: A systematic review
Nurul Adhwa Rahman et al.
BRAIN RESEARCH (2016)
In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use
Hans C. Helms et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Stem Cell-Based Human Blood-Brain Barrier Models for Drug Discovery and Delivery
S. Aday et al.
TRENDS IN BIOTECHNOLOGY (2016)
Transmembrane proteins of the tight junctions at the blood-brain barrier: Structural and functional aspects
Reiner F. Haseloff et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Anatomy and physiology of the blood-brain barrier
Yonatan Serlin et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Pilocarpine-Induced Convulsive Activity Is Limited by Multidrug Transporters at the Rodent Blood-Brain Barrier
K. Roemermann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
TEER Measurement Techniques for In Vitro Barrier Model Systems
Balaji Srinivasan et al.
JALA (2015)
Identity crisis in the PMP-22/EMP/MP20/Claudin superfamily (Pfam00822)
N. Gehne et al.
TISSUE BARRIERS (2015)
In Vitro Models of the Blood-Brain Barrier for the Study of Drug Delivery to the Brain
Imola Wilhelm et al.
MOLECULAR PHARMACEUTICS (2014)
Drug-Induced Trafficking of P-Glycoprotein in Human Brain Capillary Endothelial Cells as Demonstrated by Exposure to Mitomycin C
Andreas Noack et al.
PLOS ONE (2014)
Marked Differences in the Effect of Antiepileptic and Cytostatic Drugs on the Functionality of P-Glycoprotein in Human and Rat Brain Capillary Endothelial Cell Lines
Dana Alms et al.
PHARMACEUTICAL RESEARCH (2014)
Cell-Culture Models of the Blood-Brain Barrier
Yarong He et al.
STROKE (2014)
You Shall Not Pass-tight junctions of the blood brain barrier
Hans-Christian Bauer et al.
FRONTIERS IN NEUROSCIENCE (2014)
Potential role for human P-glycoprotein in the transport of lacosamide
Chunbo Zhang et al.
EPILEPSIA (2013)
Blood-brain barrier structure and function and the challenges for CNS drug delivery
N. Joan Abbott
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Quantitative Targeted Absolute Proteomic Analysis of Transporters, Receptors and Junction Proteins for Validation of Human Cerebral Microvascular Endothelial Cell Line hCMEC/D3 as a Human Blood-Brain Barrier Model
Sumio Ohtsuki et al.
MOLECULAR PHARMACEUTICS (2013)
Development, maintenance and disruption of the blood-brain barrier
Birgit Obermeier et al.
NATURE MEDICINE (2013)
The hCMEC/D3 cell line as a model of the human blood brain barrier
Babette Weksler et al.
FLUIDS AND BARRIERS OF THE CNS (2013)
Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies
Daniela E. Eigenmann et al.
FLUIDS AND BARRIERS OF THE CNS (2013)
The transport of antiepileptic drugs by P-glycoprotein
Chunbo Zhang et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Experimental Methods and Transport Models for Drug Delivery Across the Blood-Brain Barrier
Bingmei M. Fu
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Transcriptional Profiling of Human Brain Endothelial Cells Reveals Key Properties Crucial for Predictive In Vitro Blood-Brain Barrier Models
Eduard Urich et al.
PLOS ONE (2012)
Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation
Anny-Claude Luissint et al.
FLUIDS AND BARRIERS OF THE CNS (2012)
Do ATP-Binding Cassette Transporters Cause Pharmacoresistance in Epilepsy? Problems and Approaches in Determining which Antiepileptic Drugs are Affected
Wolfgang Loescher et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models
Kathryn Hatherell et al.
JOURNAL OF NEUROSCIENCE METHODS (2011)
Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport
Konstantin Kuteykin-Teplyakov et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Participation of the second extracellular loop of claudin-5 in paracellular tightening against ions, small and large molecules
Christian Piehl et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
N-desmethyl-Loperamide Is Selective for P-Glycoprotein among Three ATP-Binding Cassette Transporters at the Blood-Brain Barrier
Pavitra Kannan et al.
DRUG METABOLISM AND DISPOSITION (2010)
In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein
Chunbo Zhang et al.
LIFE SCIENCES (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Structure and Function of Extracellular Claudin Domains
Gerd Krause et al.
MOLECULAR STRUCTURE AND FUNCTION OF THE TIGHT JUNCTION: FROM BASIC MECHANISMS TO CLINICAL MANIFESTATIONS (2009)
Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells
Sandrine Dauchy et al.
BIOCHEMICAL PHARMACOLOGY (2009)
The Antiepileptic Drug Topiramate is a Substrate for Human P-glycoprotein but Not Multidrug Resistance Proteins
Carlos Luna-Tortos et al.
PHARMACEUTICAL RESEARCH (2009)
The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies
Birk Poller et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Several major antiepileptic drugs are substrates for human P-glycoprotein
Carlos Luna-Tortos et al.
NEUROPHARMACOLOGY (2008)
Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies
Luca Cucullo et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Differences in the transport of the antiepileptic drugs phenytoin, levetiracetarn and carbamazepine by human and mouse P-glycoprotein
Steffen Baltes et al.
NEUROPHARMACOLOGY (2007)
Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells
Sumio Ohtsuki et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Rapid assessment of p-glycoprotein-drug interactions at the blood-brain barrier
Martin Bubik et al.
ANALYTICAL BIOCHEMISTRY (2006)
Drug resistance in brain diseases and the role of drug efflux transporters
W Löscher et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells
S Amasheh et al.
CELL AND TISSUE RESEARCH (2005)
Blood-brain barrier-specific properties of a human adult brain endothelial cell line
BB Weksler et al.
FASEB JOURNAL (2005)
Selective decrease in paracellular conductance of tight junctions: role of the first extracellular domain of claudin-5
HJ Wen et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice
T Nitta et al.
JOURNAL OF CELL BIOLOGY (2003)
Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier
M Gumbleton et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro
H Franke et al.
BRAIN RESEARCH PROTOCOLS (2000)
Share Paper
